PRPO

Precipio (PRPO)

About Precipio (PRPO)

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Details

Daily high

$25.03

Daily low

$23.81

Price at open

$24.64

52 Week High

$28.50

52 Week Low

$3.90

Market cap

42.1M

Dividend yield

0.00%

Volume

16,489

Avg. volume

12,404

P/E ratio

-28.78

Precipio News